Chevy Chase Trust Holdings LLC lessened its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 91,571 shares of the company's stock after selling 2,258 shares during the period. Chevy Chase Trust Holdings LLC's holdings in HCA Healthcare were worth $35,081,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in the business. Angeles Wealth Management LLC boosted its stake in shares of HCA Healthcare by 15.5% in the 2nd quarter. Angeles Wealth Management LLC now owns 990 shares of the company's stock valued at $379,000 after purchasing an additional 133 shares in the last quarter. First National Bank of Mount Dora Trust Investment Services boosted its stake in shares of HCA Healthcare by 0.8% in the 2nd quarter. First National Bank of Mount Dora Trust Investment Services now owns 9,111 shares of the company's stock valued at $3,490,000 after purchasing an additional 68 shares in the last quarter. Nordea Investment Management AB boosted its stake in shares of HCA Healthcare by 6.8% in the 2nd quarter. Nordea Investment Management AB now owns 927,781 shares of the company's stock valued at $350,404,000 after purchasing an additional 59,163 shares in the last quarter. Turtle Creek Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at $221,000. Finally, New York State Teachers Retirement System raised its holdings in HCA Healthcare by 0.7% during the 2nd quarter. New York State Teachers Retirement System now owns 171,782 shares of the company's stock valued at $65,810,000 after buying an additional 1,118 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.
Analyst Ratings Changes
HCA has been the subject of several analyst reports. Mizuho increased their price target on shares of HCA Healthcare from $425.00 to $475.00 and gave the company an "outperform" rating in a research report on Friday. KeyCorp increased their price target on shares of HCA Healthcare from $370.00 to $465.00 and gave the company an "overweight" rating in a research report on Wednesday, October 8th. UBS Group increased their price target on shares of HCA Healthcare from $438.00 to $495.00 and gave the company a "buy" rating in a research report on Tuesday. Weiss Ratings reissued a "buy (b-)" rating on shares of HCA Healthcare in a research report on Wednesday, October 8th. Finally, Royal Bank Of Canada decreased their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a report on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $434.00.
Get Our Latest Stock Report on HCA Healthcare
HCA Healthcare Trading Up 1.4%
Shares of NYSE HCA opened at $425.50 on Friday. The firm has a fifty day simple moving average of $410.05 and a two-hundred day simple moving average of $378.21. The firm has a market capitalization of $99.56 billion, a PE ratio of 17.89, a price-to-earnings-growth ratio of 1.33 and a beta of 1.40. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $439.01.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period last year, the business earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were paid a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.
Insider Activity
In related news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.30% of the stock is currently owned by insiders.
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Stories
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.